Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
Pediatric Blood & Cancer
|
April 7, 2021
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification
Frank Berthold, Carolina Rosswog, Holger Christiansen, et al.
Neoplasia (New York, N.Y.)
|
November 2, 2017
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
Carolina Rosswog, Rene Schmidt, André Oberthuer, et al.
Cancer Medicine
|
August 20, 2025
Anthracycline-Induced Cardiomyopathy After Nephro-/Neuroblastoma in Childhood: The Importance of Cardiological Reference Assessment
Kristina Kleen, Judith Gebauer, Claudia Spix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification
André Oberthuer, Frank Berthold, Patrick Warnat, et al.
Journal of Clinical Medicine
|
October 14, 2023
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
Tim Flaadt, Martin Ebinger, Malin Schreiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Histone deacetylase 8 in neuroblastoma tumorigenesis
Ina Oehme, Hedwig E Deubzer, Dennis Wegener, et al.
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Cell & Bioscience
|
September 24, 2022
Reliable assessment of telomere maintenance mechanisms in neuroblastoma
Alina Meeser, Christoph Bartenhagen, Lisa Werr, et al.
JMIR Research Protocols
|
February 17, 2022
Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study
Oliver Zolk, Annika von dem Knesebeck, Norbert Graf, et al.
Journal of Cancer
|
July 30, 2016
Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK
Christine Damm-Welk, Faraz Siddiqi, Matthias Fischer, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
Pediatric Blood & Cancer
|
April 7, 2021
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification
Frank Berthold, Carolina Rosswog, Holger Christiansen, et al.
Neoplasia (New York, N.Y.)
|
November 2, 2017
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
Carolina Rosswog, Rene Schmidt, André Oberthuer, et al.
Cancer Medicine
|
August 20, 2025
Anthracycline-Induced Cardiomyopathy After Nephro-/Neuroblastoma in Childhood: The Importance of Cardiological Reference Assessment
Kristina Kleen, Judith Gebauer, Claudia Spix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification
André Oberthuer, Frank Berthold, Patrick Warnat, et al.
Journal of Clinical Medicine
|
October 14, 2023
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
Tim Flaadt, Martin Ebinger, Malin Schreiber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Histone deacetylase 8 in neuroblastoma tumorigenesis
Ina Oehme, Hedwig E Deubzer, Dennis Wegener, et al.
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Cell & Bioscience
|
September 24, 2022
Reliable assessment of telomere maintenance mechanisms in neuroblastoma
Alina Meeser, Christoph Bartenhagen, Lisa Werr, et al.
JMIR Research Protocols
|
February 17, 2022
Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study
Oliver Zolk, Annika von dem Knesebeck, Norbert Graf, et al.
Journal of Cancer
|
July 30, 2016
Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK
Christine Damm-Welk, Faraz Siddiqi, Matthias Fischer, et al.
Page
of 15